UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 68

of 'Systemic treatment for unresectable malignant pleural mesothelioma'

68
TI
Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307) (abstract 7707)
AU
Jahan PA, Wang XF, Krug ML, et al
SO
J Clin Oncol. 2007; 25:18s.
 
AD